NEW YORK( GenomeWeb) – LifeLabs Medical Laboratory Services today said it is offering NanoString's Prosigna Breast Cancer Prognostic Gene Signature Assay in Canada. 

LifeLabs said it is the first clinical lab in the country to offer the test, which is approved by Health Canada and cleared by the US Food and Drug Administration

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.